Stay updated on Optimal Tenecteplase Dose in Stroke Clinical Trial
Sign up to get notified when there's something new on the Optimal Tenecteplase Dose in Stroke Clinical Trial page.

Latest updates to the Optimal Tenecteplase Dose in Stroke Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 is now shown. The previous Revision: v3.4.1 note and a general government funding-status notice were removed.SummaryDifference0.3%

- Check21 days agoChange DetectedA general funding-status notice was added. The page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedNew UI/text changes include adding a Show glossary option and updating the footer to display 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. The prior footer entries 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check42 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4 with no visible changes to study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page now includes a consolidated Locations section with New South Wales, Queensland, South Australia, Victoria, and Auckland, replacing previous separate location headings; this changes how sites are listed on the page.SummaryDifference0.5%

- Check92 days agoChange DetectedPubMed-derived publications note updated to clarify that entries are automatically filled from PubMed and may not all pertain to the study, and the page shows Revision: v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Optimal Tenecteplase Dose in Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Optimal Tenecteplase Dose in Stroke Clinical Trial page.